According to Future Market Insights (FMI), the worldwide hernia mesh devices market share is projected to be worth US$ 4.5 billion in 2021 and is projected to grow to US$ 6.5 billion by 2032. The report’s conclusions indicate that 80% of all hernias will still be inguinal hernias. Ten times more common in men than in women, they are the most common type of hernia. This illustrates the increasing revenue generated by hernia mesh products.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15102
Synthetic Hernia Mesh will be the Most used Mesh for Surgery throughout the Analysis Period
According to the FDA, synthetic mesh devices are used in 90% of hernia surgeries. The robust supply chain, availability of raw materials, and lower cost are the primary reasons for synthetic mesh’s market dominance. In China, the number of hernia operations reached 1 million in 2015 and is increasing by 20-30% each year. By 2032, China’s hernia mesh device revenue is expected to reach US$ 431.1 Mn.
North America will see continued revenue growth in Hernia Mesh Market throughout the Analysis Period
North America is expected to grow at a CAGR of 3.4% over the next decade. In North America, reimbursement for hernia mesh is favourable, which encourages patients to undergo laparoscopic surgery. Patients can easily obtain comprehensive payment codes and ratios that governments and industry stakeholders have made public. Furthermore, technological advances, as well as the development and adoption of new products such as TELA Bio, are propelling the entire market forward in terms of revenue.
“Despite the 90% dominance of synthetic mesh in the Hernia Mesh device market, the biological mesh-based hernia devices can reap significant market revenue in the forthcoming years” comments an analyst at Future Market Insights.
Hernia Mesh Devices Market: Competition Insights
Most of the key players in hernia mesh devices market have been focusing on obtaining approvals from regulatory authorities. The key companies operating in the Hernia Mesh Devices market include Medtronic plc, Ethicon, and W. L. Gore and Associates, Inc., Atrium Medical Technologies, B. Braun Melsungen AG, PRIMEQUAL SA, Becton, Dickinson, and Company, Deep Blue Medical Inc., Dipromed Srl, BioCer Entwicklungs-GmbH, Betatech Medical, Sinolinks Medical Innovation, Inc, Aspide Medical S.A.S., Meril Life Sciences Pvt. Ltd., Herniamesh Srl., Changzhou Medical Equipment General Factory Co., Ltd, Gem Srl, SAMYANG HOLDING CORPORATION, Katsan Katgut Sanayi Ve Ticaret Anonim Sirketi, Novus Scientific AB.
The key recent developments of Hernia Mesh Devices manufacturers are as follows:
- Novus Scientific AB received FDA approval in March 2020 for TIGR Matrix Surgical Mesh, which is indicated for use in procedures involving soft tissue repairs, such as hernia repair or other soft tissue-related defects.
- Becton, Dickinson, and Company received FDA clearance in July 2020 for 3DMax MID Anatomical Mesh, which is indicated for use in soft tissue reinforcement and inguinal hernia repair.
- Deep Blue Medical Inc. received FDA approval to begin selling its new hernia mesh product in August 2020. Because of the product’s promising sales prospects, the company recently announced that investors have invested US$ 3.4 million in the company.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15102
Key Segments:
Key Segments Covered in Hernia Mesh Devices Market Survey
Hernia Mesh Devices Market by Mesh Type:
- Biological Mesh
- Synthetic Mesh
Hernia Mesh Devices Market by Hernia Type:
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
Top Reports Related To Healthcare Domain:
Body Fat Reduction Market Forecast: The body fat reduction market size exceeded USD 9 billion in 2021 and is expected to register over 9.9% CAGR between 2022 and 2028.
Sleep Apnea Devices Market Outlook: The sleep apnea devices market is projected to register a CAGR of 7.8% during the forecast period, up from US$ 7 Bn in 2021 to reach a valuation of US$ 9.5 Billion by 2026.
Corneal Ulcer Treatment Market Revenue: Corneal Ulcer Treatment Market is set for 1.75X growth over the next ten years. Retail pharmacies would be the preferred distribution channel, while antibiotics drug class is projected to hold 75% share in the global corneal ulcer treatment market through 2029
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube